![]() |
市場調查報告書
商品編碼
1561543
2024-2032 年冷凍治療市場報告(按產品、應用、最終用戶和地區分類)Cryotherapy Market Report by Product, Application, End User, and Region 2024-2032 |
2023年全球冷凍治療IMARC Group規模達3.299億美元。老年人口的成長、癌症盛行率的增加以及焦慮、氣喘、偏頭痛和肌肉酸痛病例的增加是推動市場發展的一些關鍵因素。
冷凍療法是指依賴極低溫度進行治療的醫學療法。它有助於減少身體疼痛,並透過促進膠原蛋白的產生來改善皮膚健康和質地。它還可以透過增加體內白血球的水平來幫助增強免疫功能。此外,冷凍療法透過收縮頭部血管和減少發炎來幫助緩解偏頭痛和頭痛。它用於治療多種疾病,包括運動傷害、關節炎、皮膚病和慢性疼痛。運動員也用它來治療運動傷害,例如肌肉拉傷,幫助加快受傷後的恢復時間並提高表現。
目前,體育健身活動的日益普及,導致運動傷害的發生率不斷上升。這是積極影響全球市場的關鍵因素之一。此外,不斷成長的老年人口和不斷增加的癌症盛行率正在推動對冷凍療法的需求,以實現快速康復、減少併發症和最大限度地縮短住院時間。再加上久坐的生活方式、不健康的飲食模式以及不斷增加的焦慮、氣喘、偏頭痛和肌肉酸痛病例,正在創造一個有利的市場前景。除此之外,社群媒體的影響力不斷增強,人們對健康和美容療程的興趣日益濃厚,再加上對皮膚病非侵入性治療的日益青睞,正在加強市場的成長。此外,對具有成本效益的治療方案的需求不斷成長,刺激了對冷凍療法的需求,作為更昂貴的治療(例如手術)的潛在替代方案。與此一致的是,用於治療發炎、類風濕性關節炎和慢性疼痛的冷凍室和冷凍桑拿室的開發正在推動市場的成長。此外,冷凍療法的可近性和可負擔性的提高也促進了市場的成長。此外,醫療保健基礎設施的顯著改善以及對研發 (R&D) 活動的廣泛投資正在推動全球市場的成長。 ,以及蓬勃發展的健康和健身產業。
The global cryotherapy market size reached US$ 329.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 539.8 Million by 2032, exhibiting a growth rate (CAGR) of 5.5% during 2024-2032. The growing geriatric population, increasing prevalence of cancer and increasing cases of anxiety, asthma, migraine, and muscle soreness represent some of the key factors driving the market.
Cryotherapy refers to a medical therapy that relies on extremely low temperatures for treatment. It helps reduce pain in the body and improves skin health and texture by promoting collagen production. It also helps boost immune function by increasing levels of white blood cells in the body. Moreover, cryotherapy aids in relieving migraines and headaches by constricting blood vessels in the head and reducing inflammation. It is employed to treat a variety of medical conditions, including sports injuries, arthritis, skin conditions, and chronic pain. It is also used by athletes to treat sports injuries, such as muscle strains, help speed up recovery time after injury, and improve performance.
At present, the growing popularity of sports and fitness activities is resulting in the increasing incidence of sports injuries. This represents one of the key factors positively influencing the market across the globe. In addition, the growing geriatric population and increasing prevalence of cancer are catalyzing the demand for cryotherapy for fast recovering, reducing complications, and minimizing hospital stays. This, in confluence with sedentary lifestyles, unhealthy dietary patterns, and increasing cases of anxiety, asthma, migraine, and muscle soreness, is creating a favorable market outlook. Apart from this, the rising influence of social media and the growing interest in wellness and beauty treatments, in confluence with the increasing preference for non-invasive treatments for skin conditions, is strengthening the market growth. Moreover, the rising demand for cost-effective treatment options is catalyzing the demand for cryotherapy as a potential alternative to more expensive treatments, such as surgeries. In line with this, the development of cryo-chambers and cryo-saunas for the treatment of inflammation, rheumatoid arthritis, and chronic pain, are fueling the market growth. Additionally, the increasing accessibility and the rising affordability of cryotherapy are contributing to the market growth. Furthermore, significant improvements in the healthcare infrastructure, along with extensive investments in research and development (R&D) activities, are fueling the growth of the market worldwide., Some of the other factors stimulating the growth of the market across the globe include inflating disposable incomes, increasing awareness about the benefits of cryotherapy, and flourishing wellness and fitness industries.
IMARC Group provides an analysis of the key trends in each sub-segment of the global cryotherapy market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end user.
The report has provided a detailed breakup and analysis of the cryotherapy market based on the product. This includes cryosurgery devices (tissue contact probes, tissue spray probes, epidermal and subcutaneous cryoablation devices), localized cryotherapy devices, and cryochambers and cryosaunas. According to the report, cryochambers and cryosaunas accounted for the largest market share.
A detailed breakup and analysis of the cryotherapy market based on the application has also been provided in the report. This includes surgical applications (oncology, cardiology, dermatology, and others), pain management, and recovery, health and beauty. According to the report, pain management accounted for the largest market share.
A detailed breakup and analysis of the cryotherapy market based on the end user has also been provided in the report. This includes hospitals and specialty clinics, cryotherapy centres, spas and fitness centres. According to the report, cryotherapy centres accounted for the largest market share.
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for cryotherapy. Some of the factors driving the North America cryotherapy market included the high disposable incomes, increasing incidences of sports injuries, rising awareness about the benefits of cryotherapy on skin conditions, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global cryotherapy market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boston Scientific Corporation, Brymill Cryogenic Systems, CooperSurgical Inc., Cortex Technology, CryoConcepts LP, Erbe Elektromedizin GmbH, Kriosystem-Care Sp. z o.o., Medtronic plc, METRUM CRYOFLEX Sp. z o.o. Sp. k., Pacira BioSciences Inc., US Cryotherapy, Zimmer MedizinSysteme GmbH, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.